Member Info for stanleyb

Ingenuity has probably had at least £1 billion thrown at it since its creation and appears to be building a decent customer base...the spin off serms to be about the correct timing as someone will no doubt see value in Ingenuity as a stand alone business. As for Nutrition and Beauty, they are already successful profitable businesses that could easily pay dividends seeing as they will no longer be subsidising Ingenuity business. The latest RNS should have seen a very positive boost to the SP but for some reason the Hedge Funds have managed to trash the news...hopefully MM will have the last laugh and patient shareholders will finally get rewarded via a dividend from Ingenuity and a big boost to THG share price as the £2 billion business starts paying dividends to shareholders. Jmo Adyor!

😴 💤 😴 💤 😴 💤 😴 💤 😴 💤

Zźźzzzzzzźzzzzzzzzzzzzzzzzzźzzzzzzzzzzzzzźzzzzzzzzźzzzzzzzzzzzzźźzźzzzzzzzzźzzzzzzzzzzzzzzzzzzzz

Zźźzzzzzzźzzzzzzzzzzzzzzzzzźzzzzzzzzzzzzzźzzzzzzzzźzzzzzzzzzzzzź

😴 💤 😴 💤 😴 💤 😴 💤 😴 💤

źzźzzzzzzzzźzzzzzzzzzzzzzzzzzzzz

Zźźzzzzzzźzzzzzzzzzzzzzzzzzźzzzzzzzzzzzzzźzzzzzzzzźzzzzzzzzzzzzźźzźzzzzzzzzźzzzzzzzzzzzzzzzzzzzz

😴 💤 😴 💤 😴 💤 😴 💤 😴 💤

Zźźzzzzzzźzzzzzzzzzzzzzzzzzźzzzzzzzzzzzzzźzzzzzzzzźzzzzzzzzzzzzźźzźzzzzzzzzźzzzzzzzzzzzzzzzzzzzz

Zźźzzzzzzźzzzzzzzzzzzzzzzzzźzzzzzzzzzzzzzźzzzzzzzzźzzzzzzzzzzzzź

😴 💤 😴 💤 😴 💤 😴 💤 😴 💤

źzźzzzzzzzzźzzzzzzzzzzzzzzzzzzzz

Zźźzzzzzzźzzzzzzzzzzzzzzzzzźzzzzzzzzzzzzzźzzzzzzzzźzzzzzzzzzzzzźźzźzzzzzzzzźzzzzzzzzzzzzzzzzzzzz

😴 💤 😴 💤 😴 💤 😴 💤 😴 💤

Zźźzzzzzzźzzzzzzzzzzzzzzzzzźzzzzzzzzzzzzzźzzzzzzzzźzzzzzzzzzzzzźźzźzzzzzzzzźzzzzzzzzzzzzzzzzzzzz

Zźźzzzzzzźzzzzzzzzzzzzzzzzzźzzzz

😴 💤 😴 💤 😴 💤 😴 💤 😴 💤

zzzzzzzzzźzzzzzzzzźzzzzzzzzzzzzźźzźzzzzzzzzźzzzzzzzzzzzzzzzzzzzz

Zźźzzzzzzźzzzzzzzzzzzzzzzzzźzzzzzzzzzzzzzźzzzzzzzzźzzzzzzzzzzzzź

😴 💤 😴 💤 😴 💤 😴 💤 😴 💤

źzźzzzzzzzzźzzzzzzzzzzzzzzzzzzzz

Zźźzzzzzzźzzzzzzzzzzzzzzzzzźzzzzzzzzzzzzzźzzzzzzzzźzzzzzzzzzzzzźźzźzzzzzzzzźzzzzzzzzzzzzzzzzzzzz

😴 💤 😴 💤 😴 💤 😴 💤 😴 💤

Zźźzzzzzzźzzzzzzzzzzzzzzzzzźzzzzzzzzzzzzzźzzzzzzzzźzzzzzzzzzzzzźźzźzzzzzzzzźzzzzzzzzzzzzzzzzzzzz

Zźźzzzzzzźzzzzzzzzzzzzzzzzzźzzzz

😴 💤 😴 💤 😴 💤 😴 💤 😴 💤

zzzzzzzzzźzzzzzzzzźzzzzzzzzzzzzźźzźzzzzzzzzźzzzzzzzzzzzzzzzzzzzz

Zźźzzzzzzźzzzzzzzzzzzzzzzzzźzzzzzzzzzzzzzźzzzzzzzzźzzzzzzzzzzzzź

😴 💤 😴 💤 😴 💤 😴 💤 😴 💤

źzźzzzzzzzzźzzzzzzzzzzzzzzzzzzzz

Zźźzzzzzzźzzzzzzzzzzzzzzzzzźzzzzzzzzzzzzzźzzzzzzzzźzzzzzzzzzzzzźźzźzzzzzzzzźzzzzzzzzzzzzzzzzzzzz

😴 💤 😴 💤 😴 💤 😴 💤 😴 💤

Zźźzzzzzzźzzzzzzzzzzzzzzzzzźzzzzzzzzzzzzzźzzzzzzzzźzzzzzzzzzzzzźźzźzzzzzzzzźzzzzzzzzzzzzzzzzzzzz

Zźźzzzzzzźzzzzzzzzzzzzzzzzzźzzzz

😴 💤 😴 💤 😴 💤 😴 💤 😴 💤

zzzzzzzzzźzzzzzzzzźzzzzzzzzzzzzźźzźzzzzzzzzźzzzzzzzzzzzzzzzzzzzz

Zźźzzzzzzźzzzzzzzzzzzzzzzzzźzzzzzzzzzzzzzźzzzzzzzzźzzzzzzzzzzzzź

😴 💤 😴 💤 😴 💤 😴 💤 😴 💤

źzźzzzzzzzzźzzzzzzzzzzzzzzzzzzzz

Zźźzzzzzzźzzzzzzzzzzzzzzzzzźzzzzzzzzzzzzzźzzzzzzzzźzzzzzzzzzzzzź

😴 💤 😴 💤 😴 💤 😴 💤 😴 💤

😴 💤 😴 💤 😴 💤 😴 💤 😴

😴 💤 😴 💤 😴 💤 😴 💤 😴 💤

Kelso, I assume that you don't own any HVO? What's your top ten list then? I'll sell half my HVO shares and buy your top 10 instead or are you just trolling?

You make a fair point, but the company has burnt through vast amounts of cash and keep raising huge sums that continue to dilute shareholders, is that not the case as seen in yet another £60 million raised in October?

You must admit JS appears to be talking a lot of waffle. Every time we hear something it's all about long runways and Capital Light. None of that actually means anything if Polb can sell anything to anyone does it. I thought the big news everyone was waiting for was successful data from the Polb-001 trial, well that's gone down like a lead balloon hasn't it?

It all about sales and profit. Hvivo appear on a far better financial footing with 5x sales and zero cash burn, paying a dividend and making money. AVCT have very low sales compared to Hvivo and AVCT appear to be burning through over £30 million per year at the present rate with little prospect of making a profit any time soon? Therefore I cant understand why AVCT are worth three times as much. If were talking about successful drug trials, then Hvivo have a stage 3 ready universal Influenza vaccine and another stage 2 ready mosquito vaccine in their Imutex JV that is sat on the books at zero value as per Tuesdays final results. Answers on a postcard.

Hvivo valuation appears crazy low? Let's compare to today's AVCT results.

AVCT numbers:
Revenues of £9.7 million (Hvivo £50 million)
Adjusted EBITDA loss (before non-cash and non-recurring items) of £15.1 million.
Operating loss of £32.6 million
Reported loss from continuing operations of £39.5 million
Cash and short-term deposit balances at 31 December 2022 of £41.8 million

So AVCT have less than 20% of Hvivo sales, slightly more cash following a £60 million fund raise in October 2022, burning through mountains of cash, yet AVCT has a valuation of circa £350 million compared to Hvivo's £100 million. Hvivo paid a dividend and profitable. Seems crazy to me?

Not sure what Hvivo could buy that would fit the Hvivo model, seeing as Human Challenge studies is such a unique business to Hvivo and no serious competition from anywhere else. Maybe lab services could be part of the expansion considering the recent US Lab accreditation gained?

You sound very sensible, I'll take your advice and hold on for the next update.

I don't know what you are talking about, I bought some of these at the IPO and it's a dog. Who's moniman?

As I said earlier today, the two Imutex assets are still work in progress, but best to dampen expectations and write the value down to zero in the present climate as good accounting practice. If there were to be a buyout at some point in the future, then the Imutex assets would probably be hived off to existing shareholders like Poolbeg was.

Green my thoughts exactly. The non core assets mentioned in today's results was a tidying up exercise for accounting purposes etc. Zero value gives zero expectations so that potential institutional investors or potential takeover company can see exactly what they are getting. As for Imutex, their two assets are still work in progress and could hit the market anytime without any pre announcements. As for Hvivo core business, doing exactly as planned, solid growth, big partners, cash balance ahead of expectations and paying a dividend to LTH's. Great job by the look of things.

So what are you still doing here?

Lol, how many FTSE companies have had 30% growth in the past 12 months. NONE. How many FTSE companies have zero debt? Very few if any? How many AIM companies are paying dividends? You appear a little bitter than DIM etc has been put on the back burner, maybe time you moved on to the next gold rush?

How long before a takeover is announced? Despite CF being slightly bonkers, he has employed the right team to create a profitable cash generative, zero debt company that's now paying a dividend, all within 3 years. Not bad really is it?

....and how many AIM companies are paying a dividend, have £28 million in cash? None that I can think of?

30% growth last year and prudent 10% growth this coming year. How many FTSE 100 companies have growth figures like that and zero debt on the books? None

Prudent to write down nominal valued dormant assets. The company appears to be looking at being a cash generation, dividend paying CRO and putting previous Hvivo assets in the freezer. Makes the company more credible to serious investors and institutions by the tone of the results.

I'm expecting more hot air, but maybe Hvivo will actually deliver something for its shareholders for once instead of jam tomorrow promises that don't materialise?

Jeremy appears to be full of hot air by the look of things and the dismall SP performance dince IPO!. What happened to the 'Transformational' news from the Polb-001 successful HC trial?....Is he getting his blarney from CF, I hope not? Let's hope we actually have real news soon as LTH's are definitely not seeing any returns here or any chance of a windfall dividend unless Polb-001,002 or 003 actually come good. Maybe JS should only draw a salary if something is actually delivered instead of fancy words about "Long runways"or "Capital Light model"...